Search Results - "Chang, Peter M.H"
-
1
Apical root resorption in orthodontic patients with en-masse maxillary anterior retraction and intrusion with miniscrews
Published in American journal of orthodontics and dentofacial orthopedics (01-02-2010)“…Introduction The purposes of this retrospective study were to investigate the apical root resorption of maxillary incisors in orthodontic patients with…”
Get full text
Journal Article -
2
Trifluoperazine, an Antipsychotic Agent, Inhibits Cancer Stem Cell Growth and Overcomes Drug Resistance of Lung Cancer
Published in American journal of respiratory and critical care medicine (01-12-2012)“…Cancer stem cell (CSC) theory has drawn much attention, with evidence supporting the contribution of stem cells to tumor initiation, relapse, and therapy…”
Get full text
Journal Article -
3
Novel immune‐modulating drugs for advanced head and neck cancer
Published in Head & neck (01-10-2019)“…Background Recently, two anti‐PD‐1 immune checkpoint inhibitors, pembrolizumab and nivolumab, have been approved by the US Food and Drug Administration for…”
Get full text
Journal Article -
4
Identification of Withaferin A as a Potential Candidate for Anti-Cancer Therapy in Non-Small Cell Lung Cancer
Published in Cancers (17-07-2019)“…Low response rate and recurrence are common issues in lung cancer; thus, identifying a potential compound for these patients is essential. Utilizing an in…”
Get full text
Journal Article -
5
The assessment of anticoagulant activity to predict bleeding outcome in atrial fibrillation patients receiving dabigatran etexilate
Published in Blood coagulation & fibrinolysis (01-06-2016)“…Special circumstances may require the measurement of the anticoagulant effect of dabigatran etexilate. No data currently link any given coagulation test to…”
Get full text
Journal Article -
6
A Preclinical Evaluation of Antimycin A as a Potential Antilung Cancer Stem Cell Agent
Published in Evidence-based complementary and alternative medicine (01-01-2013)“…Drug resistance and tumor recurrence are major obstacles in treating lung cancer patients. Accumulating evidence considers lung cancer stem cells (CSCs) as the…”
Get full text
Journal Article